FDA Inspection 1271235 — Czech-Gen, A.S.

Czech-Gen, A.S. — FEI 3002806982

The FDA completed an inspection of Czech-Gen, A.S. on Sep 26, 2024 in Olomouc. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 26, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Olomouc (Czech Republic)

Additional Details

Mutual Recognition Agreement (MRA)